Home / Non-selective Dopamine Receptor Agonists / Bromocriptine mesylate

Bromocriptine mesylate

Catalog #: 0427
3 Citations Datasheet
Catalog # Availability Size / Price Qty
0427/50
Bromocriptine mesylate | CAS No. 22260-51-1 | Non-selective Dopamine Receptor Agonists
1 Image
Description: D2-like agonist (D2>D3>D4)

Chemical Name: (5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate

Purity: ≥98%

Product Details
Citations (3)
Supplemental Products
Reviews
Biological Activity Technical Data Background Product Datasheets Calculators

Biological Activity

Bromocriptine mesylate is a selective D3 and D2 dopamine receptor agonist (Ki values are ~ 5 nM and ~ 8 nM respectively). Activates both isoforms of D2 receptor (EC50 values are 0.10-0.12 nM and 4.4 nM for D2L and D2S receptors, respectively. Bromocriptine shows anti-Aβ effects that are increased in combination with Cromolyn (Cat. No. 6424) and Topiramate (Cat. No. 3620). Also lowers glucose and increases insulin sensitivity in vivo.

Technical Data

M.Wt:
750.7
Formula:
C32H40BrN5O5.CH3SO3H
Solubility:
Soluble to 100 mM in DMSO
Purity:
≥98%
Storage:
Store at RT
CAS No:
22260-51-1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Background References

  1. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death.
    Fox JT, Sakamuru S, Huang R
    Proc. Natl. Acad. Sci. U.S.A., 2012;109(14):5423-8.
  2. Bromocriptine produces decreases in cocaine self-administration in the rat.
    Aubner et al.
    Neuropsychopharmacology, 1990;3:101
  3. Bromocriptine in Parkinson disease.
    Lieberman and Goldstein
    Pharmacol.Rev., 1985;37:217
  4. DA receptor pharmacology.
    Seeman and Van Tol
    Trends Pharmacol.Sci., 1994;15:264
  5. The effects of chronic bromocri. treatment on behaviour and DA receptor binding in the rat striatum.
    Traub et al.
    Eur.J.Pharmacol., 1985;118:147

Product Datasheets

COA view current batch
Or select another batch:
View Batch
SDS

Citations for Bromocriptine mesylate

The citations listed below are publications that use Tocris products. Selected citations for Bromocriptine mesylate include:

3 Citations: Showing 1 - 3

  1. A novel luminescence-based-β-arrestin recruitment assay for unmodified receptors.
    Authors: Pedersen Et al.
    J Biol Chem  2021;296:100503
  2. Identification and validation of the DA agonist bromocri. as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
    Authors: Liberante Et al.
    Oncotarget  2016;7:6609
  3. Age-dependent regulation of synaptic connections by DA D2 receptors.
    Authors: Jia Et al.
    Nat Neurosci  2013;16:1627

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Reviews for Bromocriptine mesylate

There are currently no reviews for this product. Be the first to review Bromocriptine mesylate and earn rewards!

Have you used Bromocriptine mesylate?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review
Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.